Dimensional Fund Advisors’s iBio IBIO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-24,150
Closed -$97.1K 3296
2025
Q1
$97.1K Hold
24,150
﹤0.01% 3204
2024
Q4
$59.2K Buy
24,150
+79
+0.3% +$203 ﹤0.01% 3278
2024
Q3
$53.4K Buy
+24,071
New +$47.5K ﹤0.01% 3291
2023
Q2
Sell
-3,680
Closed -$153K 3497
2023
Q1
$153K Hold
3,680
﹤0.01% 3247
2022
Q4
$33 Buy
+3,680
New +$125K ﹤0.01% 3432
2014
Q3
Sell
-25
Closed -$52K 3554
2014
Q2
$52K Hold
25
﹤0.01% 3435
2014
Q1
$68K Hold
25
﹤0.01% 3428
2013
Q4
$42K Hold
25
﹤0.01% 3429
2013
Q3
$55K Sell
25
-2
-7% -$4.78K ﹤0.01% 3439
2013
Q2
$57K Buy
+27
New +$62.2K ﹤0.01% 3432

Other funds holding IBIO

Dimensional Fund Advisors's IBIO Position: Q2 2025 in Review

Dimensional Fund Advisors sold out of iBio (IBIO) in Q2 2025, closing a stake of 24,150 shares — an estimated $97.1K sold.

Dimensional Fund Advisors first reported a position in IBIO in Q2 2013 and held it in 10 quarters. The position peaked at $153K in Q1 2023. 30 funds tracked by Wall St. Rank hold IBIO as of Q2 2025.

  • Dimensional Fund Advisors reported no remaining iBio position as of Q2 2025 after selling out during the quarter.
  • Dimensional Fund Advisors sold 24,150 iBio shares in Q2 2025, an estimated $97.1K.
  • Dimensional Fund Advisors first reported a position in iBio in Q2 2013 and held it in 10 quarters.
  • Dimensional Fund Advisors's iBio position peaked at $153K in Q1 2023.
  • 30 funds tracked by Wall St. Rank held iBio as of Q2 2025.

Based on Dimensional Fund Advisors's 13F filing for Q2 2025, filed 12 Aug 2025.